paracentesis
Jump to navigation
Jump to search
Introduction
An invasive procedure consisting of insertion of a needle through the abdominal wall into the peritoneal cavity for the purpose of removing ascitic fluid for diagnostic or therapeutic reasons.
Indications
- ascitic fluid analysis to establish etiology of ascites
- diagnosis of peritonitis:
- 25% of patients admitted to the hospital have evidence of peritonitis
- laparoscopy with histologic analysis of biopsy specimens is more sensitive for tuberculous peritonitis
- abdominal distension* with
* therapeutic removal of ascites fluid
Contraindications
- underlying coagulopathy is rarely a contraindication
- no data to support prophylactic fresh frozen plasma
Laboratory
Procedure
Preparation:
- sterile field
- gloves
- mask, gown, & hat not essential
- 60 cc syringe
- 1.5 inch 18-22 gauge needle
- 1 liter evacuated collection bottle
- sterile plastic tubing
Technique:
- site of insertion
- below umbilicus, above bladder
- midline or lateral to the inferior epigastric arteries
- avoid vascular areas midline above umbilicus
- avoid lung lateral above umbilicus
- avoid areas adjacent to scar tissue
- risk of hematoma secondary to blood vessel puncture
- risk of perforated viscus adherent to surgical scar
- empty bladder before midline insertion
- Z track entry to prevent leakage of ascitic fluid when the needle is removed
- retract skin cadually
- insert needle
- release skin when peritoneum is entered
Management
- albumin may be useful to delay recurrence of ascites[2]
- recommended if large volume (> 5 L) pracentesis[3]
More general terms
Additional terms
References
- ↑ Saunders Manual of Medical Practice, Rakel (ed), WB Saunders, Philadelphia, 1996, pg 367-68
- ↑ 2.0 2.1 Bari K et al. The combination of octreotide and midodrine is not superior to albumin in preventing recurrence of ascites after large-volume paracentesis. Clin Gastroenterol Hepatol 2012 Oct; 10:1169 PMID: https://www.ncbi.nlm.nih.gov/pubmed/22801062
- ↑ 3.0 3.1 Garcia-Tsao G et al. AGA clinical practice update on the use of vasoactive drugs and intravenous albumin in cirrhosis: Expert review. Gastroenterology 2024 Jan; 166:202. PMID: https://www.ncbi.nlm.nih.gov/pubmed/37978969 https://www.gastrojournal.org/article/S0016-5085(23)05143-0/fulltext